Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Russo

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
A phase I study of cantuzumab mertansine administered as a single intravenous infusion once weekly in patients with advanced solid tumorsPaul R Helft, Richard L Schilsky, Frank J Hoke, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 9, 2010
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United StatesElizabeth A Pomfret, Kenneth Washburn, Christoph Wald, et al.
Circulation. Cardiovascular Quality and Outcomes|January 18, 2022
Time-of-Day and Clinical Outcomes After Surgical or Transcatheter Aortic Valve Replacement: Insights From the PARTNER TrialsFlavien Vincent, Vinod H Thourani, Julien Ternacle, et al.
Circulation. Cardiovascular Interventions|June 16, 2021
Utilization, Costs, and Outcomes of Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve ReplacementHoward C Herrmann, David J Cohen, Rebecca T Hahn, et al.
The New England Journal of Medicine|September 21, 2023
Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 MutationsEric Bouffet, Jordan R Hansford, Maria Luisa Garrè, et al.
Journal of the American College of Cardiology|May 20, 2022
Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve ReplacementPhilippe Généreux, Philippe Pibarot, Björn Redfors, et al.
Journal of the American College of Cardiology|February 22, 2023
Cardiac Damage and Quality of Life After Aortic Valve Replacement in the PARTNER TrialsPhilippe Généreux, David J Cohen, Philippe Pibarot, et al.
JACC. Cardiovascular Interventions|July 23, 2021
Postoperative Atrial Fibrillation or Flutter Following Transcatheter or Surgical Aortic Valve Replacement: PARTNER 3 TrialBahira Shahim, S Chris Malaisrie, Isaac George, et al.
Lancet (London, England)|March 29, 2024
Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm studyTorsten P Vahl, Vinod H Thourani, Raj R Makkar, et al.
Lancet (London, England)|October 30, 2025
Percutaneous transcatheter valve replacement in individuals with mitral regurgitation unsuitable for surgery or transcatheter edge-to-edge repair: a prospective, multicountry, single-arm trialMayra E Guerrero, David V Daniels, Raj R Makkar, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
A phase I study of cantuzumab mertansine administered as a single intravenous infusion once weekly in patients with advanced solid tumorsPaul R Helft, Richard L Schilsky, Frank J Hoke, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 9, 2010
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United StatesElizabeth A Pomfret, Kenneth Washburn, Christoph Wald, et al.
Circulation. Cardiovascular Quality and Outcomes|January 18, 2022
Time-of-Day and Clinical Outcomes After Surgical or Transcatheter Aortic Valve Replacement: Insights From the PARTNER TrialsFlavien Vincent, Vinod H Thourani, Julien Ternacle, et al.
Circulation. Cardiovascular Interventions|June 16, 2021
Utilization, Costs, and Outcomes of Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve ReplacementHoward C Herrmann, David J Cohen, Rebecca T Hahn, et al.
The New England Journal of Medicine|September 21, 2023
Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 MutationsEric Bouffet, Jordan R Hansford, Maria Luisa Garrè, et al.
Journal of the American College of Cardiology|May 20, 2022
Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve ReplacementPhilippe Généreux, Philippe Pibarot, Björn Redfors, et al.
Journal of the American College of Cardiology|February 22, 2023
Cardiac Damage and Quality of Life After Aortic Valve Replacement in the PARTNER TrialsPhilippe Généreux, David J Cohen, Philippe Pibarot, et al.
JACC. Cardiovascular Interventions|July 23, 2021
Postoperative Atrial Fibrillation or Flutter Following Transcatheter or Surgical Aortic Valve Replacement: PARTNER 3 TrialBahira Shahim, S Chris Malaisrie, Isaac George, et al.
Lancet (London, England)|March 29, 2024
Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm studyTorsten P Vahl, Vinod H Thourani, Raj R Makkar, et al.
Lancet (London, England)|October 30, 2025
Percutaneous transcatheter valve replacement in individuals with mitral regurgitation unsuitable for surgery or transcatheter edge-to-edge repair: a prospective, multicountry, single-arm trialMayra E Guerrero, David V Daniels, Raj R Makkar, et al.
Pageof 8